Members |
targetComponentId |
Carbon dioxide measurement |
Measurement of partial pressure of carbon dioxide in blood |
Carbon tetrachloride |
Carbon tetrachloride |
Carboplatin 600mg/60mL infusion |
Antineoplastic agent |
Carboprost 250micrograms/mL injection solution 1mL ampule |
Carboprost (as carboprost trometamol) 250 microgram/mL solution for injection |
Carbuncle/boil |
Carbuncle (disorder) |
Carbuncle/boil |
Furuncle (disorder) |
Carcinoembryonic antigen present |
Carcinoembryonic antigen within reference range |
Carcinoembryonic antigen present |
Carcinoembryonic antigen above reference range (finding) |
Carcinoembryonic antigen: (& level) |
Carcinoembryonic antigen |
Carcinoembryonic antigen: (& level) |
Carcinoembryonic antigen |
Carcinoma cervix uteri: [adenocarcinoma] or [invasive] |
Adenocarcinoma of cervix |
Carcinoma cervix uteri: [adenocarcinoma] or [invasive] |
Adenocarcinoma of cervix |
Carcinoma gallbladder |
Malignant tumor of gallbladder |
Carcinoma gallbladder |
Primary malignant neoplasm of gallbladder (disorder) |
Carcinoma gallbladder |
Carcinoma of gallbladder (disorder) |
Carcinoma in situ of biliary system (& [and liver]) |
Carcinoma in situ of liver and/or biliary system (disorder) |
Carcinoma in situ of biliary system (& [and liver]) |
Carcinoma in situ of biliary tract |
Carcinoma in situ of cervix |
Cervical intraepithelial neoplasia |
Carcinoma in situ of cervix |
Cervical smear - severe dyskaryosis |
Carcinoma in situ of cervix |
Carcinoma in situ of uterine cervix |
Carcinoma in situ of digestive sytem: [organs] or [G.I. tract] |
Carcinoma in situ of digestive organ |
Carcinoma in situ of digestive sytem: [organs] or [G.I. tract] |
Carcinoma in situ of gastrointestinal tract |
Carcinoma in situ of lacrimal drainage structure |
Carcinoma in situ of lacrimal drainage system (disorder) |
Carcinoma in situ of lacrimal drainage structure |
Carcinoma in situ of lacrimal gland duct (disorder) |
Carcinoma in situ of lacrimal duct |
Carcinoma in situ of nasolacrimal duct (disorder) |
Carcinoma in situ of lacrimal duct |
Carcinoma in situ of lacrimal gland duct (disorder) |
Carcinoma in situ of lip, oral cavity and pharynx NOS |
Carcinoma in situ of mouth |
Carcinoma in situ of lip, oral cavity and/or pharynx |
Carcinoma in situ of mouth |
Carcinoma in situ of lip, oral cavity and/or pharynx |
Carcinoma in situ of lip |
Carcinoma in situ of lip, oral cavity and/or pharynx |
Carcinoma in situ of pharynx |
Carcinoma in situ of orbit |
Neoplasm of orbit |
Carcinoma in situ of other site of breast |
Carcinoma in situ of breast |
Carcinoma in situ of respiratory system: [other specified parts] or [nasal sinuses] |
Carcinoma in situ of respiratory system |
Carcinoma in situ of skin of leg |
Carcinoma in situ of skin of lower leg |
Carcinoma in situ of skin of leg |
Carcinoma in situ of skin of lower limb |
Carcinoma in situ of skin of lower arm |
Carcinoma in situ of skin of forearm |
Carcinoma in situ of skin of lower limb and hip |
Carcinoma in situ of skin of lower limb |
Carcinoma in situ of skin of lower limb and hip |
Carcinoma in situ of skin of hip |
Carcinoma in situ of skin of lower limb or hip NOS |
Carcinoma in situ of skin of lower limb |
Carcinoma in situ of skin of trunk, excluding scrotum |
Carcinoma in situ of skin of trunk |
Carcinoma in situ of skin of upper limb and shoulder |
Carcinoma in situ of skin of shoulder |
Carcinoma in situ of uterus: [other and unspecified parts] or [body] |
Carcinoma in situ of female genital organ |
Carcinoma in situ of uterus: [other and unspecified parts] or [body] |
Carcinoma in situ of body of uterus |
Carcinoma in situ: [lip] or [oral cavity] or [pharynx] |
Carcinoma in situ of mouth |
Carcinoma of epididymis/spermatic cord |
Carcinoma of epididymis and spermatic cord (disorder) |
Carcinoma of epididymis/spermatic cord |
Primary malignant neoplasm of spermatic cord (disorder) |
Carcinoma of epididymis/spermatic cord |
Primary malignant neoplasm of epididymis |
Carcinoma of esophagus |
Carcinoma of esophagus (disorder) |
Carcinoma of esophagus |
Malignant tumour of oesophagus |
Carcinoma of esophagus |
Primary malignant neoplasm of esophagus (disorder) |
Carcinoma of head of pancreas |
Carcinoma of head of pancreas |
Carcinoma of head of pancreas |
Primary malignant neoplasm of head of pancreas (disorder) |
Carcinoma of head of pancreas |
Malignant tumor of head of pancreas |
Carcinoma of lung parenchyma |
Malignant tumour of lung parenchyma |
Carcinoma of middle lobe, bronchus or lung |
Carcinoma in situ of lung |
Carcinoma of middle lobe, bronchus or lung |
Malignant neoplasm of middle lobe bronchus |
Carcinoma of middle lobe, bronchus or lung |
Primary malignant neoplasm of lung |
Carcinoma of middle lobe, bronchus or lung |
Malignant neoplasm of middle lobe of right lung (disorder) |
Carcinoma of oesophagus |
Carcinoma of esophagus (disorder) |
Carcinoma of oesophagus |
Malignant tumour of oesophagus |
Carcinoma of oesophagus |
Primary malignant neoplasm of esophagus (disorder) |
Carcinoma of pancreas |
Carcinoma of pancreas (disorder) |
Carcinoma of pancreas |
Carcinoma of pancreas (disorder) |
Carcinoma of respiratory tract and intrathoracic organs |
Neoplasm of respiratory tract |
Carcinoma of stomach |
Primary malignant neoplasm of stomach (disorder) |
Carcinoma of stomach |
Primary malignant neoplasm of stomach (disorder) |
Carcinoma of stomach |
Carcinoma of stomach (disorder) |
Carcinoma of stomach |
Malignant tumor of stomach |
Carcinoma of stomach |
Carcinoma of stomach (disorder) |
Carcinoma of stomach |
Malignant tumor of stomach |
Carcinoma of upper lobe, bronchus or lung |
Carcinoma in situ of upper lobe bronchus and lung |
Carcinoma of vocal cord |
Carcinoma of vocal cord (disorder) |
Cardiac Tc-99m methoxyisobutyl isonitrile study |
Radionuclide imaging of myocardium using technetium (99m-Tc) sestamibi (procedure) |
Cardiac adrenergic blocking agent |
Product containing beta adrenergic receptor antagonist (product) |
Cardiac adrenergic blocking agent |
Pharmaceutical / biologic product (product) |
Cardiac adrenergic blocking product |
Product containing beta adrenergic receptor antagonist (product) |
Cardiac adrenergic blocking product |
Pharmaceutical / biologic product (product) |
Cardiac akinesia |
Cardiac akinesia |
Cardiac akinesia |
Ventricular asynergy |
Cardiac arrest |
Cardiac arrest (disorder) |
Cardiac arrest |
Asystole (disorder) |
Cardiac arrest |
Cardiorespiratory arrest (disorder) |
Cardiac arrest |
Cardiorespiratory arrest (disorder) |
Cardiac arrest |
Asystole (disorder) |
Cardiac arrest |
Cardiac arrest (disorder) |
Cardiac arrest |
Cardiorespiratory failure (disorder) |
Cardiac arrest |
Cardiorespiratory arrest (disorder) |
Cardiac arrest |
Cardiac arrest (disorder) |
Cardiac arrest |
Cardiorespiratory failure (disorder) |
Cardiac arrest |
Cardiorespiratory failure (disorder) |
Cardiac arrest during AND/OR resulting from a procedure |
Cardiac arrest due to procedure (disorder) |
Cardiac arrest during AND/OR resulting from a procedure |
Cardiac arrest during procedure (disorder) |
Cardiac arrest following abortive pregnancy |
Induced termination of pregnancy complicated by cardiac arrest |
Cardiac catheter guidewire, reprocessed |
Cardiac catheter guidewire |
Cardiac catheter guidewire, single-use |
Cardiac catheter guidewire |
Cardiac complications of care (& [post operative]) |
Postoperative cardiac complication |
Cardiac complications of care (& [post operative]) |
Cardiac complication |
Cardiac depressant agent |
Pharmaceutical / biologic product (product) |
Cardiac disease monitoring |
Cardiac disease monitoring |
Cardiac disease monitoring |
Hypertension monitoring |
Cardiac disease monitoring (& [hypertension]) |
Hypertension monitoring |